NEW YORK (GenomeWeb News) – Invitrogen has signed a non-binding letter of intent to collaborate with the International Regulome Consortium on the development of stem cell research tools, the firms announced yesterday at the Biotechnology Industry Organization annual meeting in San Diego.
 
Under terms of the pact, Invitrogen will contribute unspecified services and technologies to help IRC researchers map the “genetic circuit board” that regulates how stem cells give rise to specialized cells, such as neurons.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.